As shown in Fig. 7B,C, DOX treatment resulted in a 38% reduction in ALDH-1 expression levels as estimated by immunohistochemistry, however, no significant changes were observed in its level in the corresponding tumor tissue homogenates when estimated using ELISA. This evidence concerns the gene ALDH1A1 and neoplasm.